SCHEMBL7008019

SCHEMBL7008019

CN(C)Cc1cnc(-c2cc3c(Nc4ccc(OCc5ccccc5)cc4)ncnc3cn2)[nH]1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ERBB2 P04626 14/20 0.57
EGFR P00533 13/20 0.55
AURKB Q96GD4 3/20 0.53
ERBB4 Q15303 2/20 0.53
CHEK2 O96017 1/20 0.53
ROS1 P08922 1/20 0.53
FLT3 P36888 1/20 0.53
CLK4 Q9HAZ1 1/20 0.53
MKNK2 Q9HBH9 1/20 0.53
TTBK1 Q5TCY1 1/20 0.48
TTBK2 Q6IQ55 1/20 0.48
INCENP Q9NQS7 1/20 0.48
MEN1 O00255 1/20 0.43
NPC1 O15118 1/20 0.43
TP53 P04637 1/20 0.43
MAPT P10636 1/20 0.43
HPGD P15428 1/20 0.43
HTT P42858 1/20 0.43
RAB9A P51151 1/20 0.43
KMT2A Q03164 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8458493 0.93 ERBB2 (0.57) ERBB2EGFRAURKBERBB4CHEK2
SCHEMBL8458496 0.88 ERBB2 (0.55) ERBB2EGFRAURKBERBB4CHEK2
SCHEMBL6767948 0.88 EGFR (0.60) ERBB2EGFRAURKBERBB4CHEK2
SCHEMBL7007455 0.84 ERBB2 (0.53) ERBB2EGFRAURKBERBB4CHEK2
SCHEMBL7008017 0.83 ERBB2 (0.57) ERBB2EGFRAURKBERBB4CHEK2
SCHEMBL7004232 0.82 ERBB2 (0.56) ERBB2EGFRAURKBERBB4CHEK2
SCHEMBL4359057 0.81 ERBB2 (0.79) ERBB2EGFRAURKBERBB4CHEK2
SCHEMBL7880662 0.80 ERBB2 (0.62) ERBB2EGFRAURKBERBB4CHEK2
SCHEMBL7004234 0.80 ERBB2 (0.55) ERBB2EGFRAURKBERBB4CHEK2
SCHEMBL7890142 0.79 EGFR (0.67) ERBB2EGFRAURKBERBB4CHEK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0912572-B1 BICYCLIC HETEROAROMATIC COMPOUNDS AS PROTEIN TYROSINE KINASE INHIBITORS GLAXO GROUP LTD (GB) 2003-01-15 EP disclosed
US-6207669-B1 IN TREATMENT OF CANCER AND PSORIASIS GLAXO WELLCOME INC. 2001-03-27 US disclosed
CN-1230185-A Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors GLAXO GROUP LTD (GB) 1999-09-29 CN disclosed
EP-0912572-A1 BICYCLIC HETEROAROMATIC COMPOUNDS AS PROTEIN TYROSINE KINASE INHIBITORS GLAXO GROUP LIMITED (GB) 1999-05-06 EP disclosed
WO-1998002437-A1 BICYCLIC HETEROAROMATIC COMPOUNDS AS PROTEIN TYROSINE KINASE INHIBITORS GLAXO GROUP LIMITED (GB) 1998-01-22 WO disclosed